Dec 18, 2022
New Compound Reverses Gut Inflammation — Acts Like a Master Reset Switch in the Intestines
Posted by Paul Battista in category: biotech/medical
New therapeutic has the potential to treat inflammatory bowel disease by targeting a molecule that keeps order in the intestines.
Salk Institute scientists have developed a new drug that acts like a master reset switch in the gut. Called FexD, the compound has previously been found to burn fat, lower cholesterol, and ward off colorectal cancer in mice. Now, the team reports that FexD can also prevent and reverse intestinal inflammation in mouse models of inflammatory bowel disease. The study was published on December 12, 2022, in the journal Proceedings of the National Academy of Sciences.
“The Salk-developed drug FexD provides a new way to restore balance to the digestive system and treat inflammatory diseases that are currently very difficult to manage,” says Salk Professor Ronald Evans, senior author of the study. Evans is also director of Salk’s Gene Expression Laboratory and March of Dimes Chair in Molecular and Developmental Biology.